We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $47.2M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-3.1%
1 Year Est. Return
+32.31%
3 Year Est. Return
+200.03%
5 Year Est. Return
10 Year Est. Return
AUM
$47.2M
AUM Growth
-$6.64M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$926M
$26.7M 56.53%
4,588,284
IVVD icon
2
Invivyd
IVVD
$235M
$8.07M 17.11%
9,248,250
TGTX icon
3
TG Therapeutics
TGTX
$8.6B
$4.85M 10.29%
88,354
ARWR icon
4
Arrowhead Research
ARWR
$12.1B
$3M 6.37%
36,851
GUTS icon
5
Fractyl Health
GUTS
$110M
$1.47M 3.13%
1,856,117
PRQR icon
6
ProQR Therapeutics
PRQR
$295M
$1.12M 2.37%
599,793
SLN
7
Silence Therapeutics
SLN
$914M
$1.11M 2.36%
101,203
RCKT icon
8
Rocket Pharmaceuticals
RCKT
$414M
$721K 1.53%
210,871
CRIS icon
9
Curis
CRIS
$3.2M
$149K 0.32%
14,244

Similar funds

M28 Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, M28 Capital Management held 9 positions worth $47.2M, down 12% from $53.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. M28 Capital Management opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • M28 Capital Management's ten largest holdings make up 100% of its $47.2M portfolio in Q2 2026.
  • M28 Capital Management opened 0 new positions and closed 0 in Q2 2026.
  • M28 Capital Management's portfolio value fell 12% quarter-over-quarter to $47.2M.

Based on M28 Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.